Gosuranemab (BMS-986168, IPN007) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemab neutralizes the extracellular tau protein, inhibiting the spread and aggregation of pathological tau protein. Gosuranemab can be used for the researches of alzheimers disease (AD) and progressive supranuclear palsy (PSP)[1][2].
Molecular Weight:
(144.94 kDa)
Purity:
97.31
CAS Number:
[1788032-39-2]
Target:
Tau Protein
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted